All Stories

  1. First Step in Generalizability and Clinical Application of Ultralow or Fluoroless Cardiac Implantable Electronic Device Implantation Using Ultrasound
  2. Permanent Pacemaker After Transcatheter Aortic Valve Implantation in Baseline Right Bundle Branch Block: A Pathway, Not a Label
  3. Prolonged Loop Recorder Retention: Safety, Diagnostic Yield, and the Case for Community-Based Explantation
  4. Vagally mediated syncope leading to disabling of high-pass filter and inappropriate therapy from an S-ICD: A case report
  5. Scope and Outcome of Early Repolarization Syndrome in Unexplained Cardiac Arrest: Insights From the National HiRO Registry
  6. Mechanical Thrombectomy Versus Anticoagulation in Intermediate‐Risk Pulmonary Embolism: A Risk‐Stratified, Propensity Score–Matched Analysis
  7. Epinephrine Challenge
  8. Paradoxical embolism from a migrated right atrial ‘lead ghost’ through an unrecognized patent foramen ovale after cardiac resynchronization therapy–defibrillator lead extraction: a case report
  9. Fluoroless Implantation of Pacemaker and Cardioverter-Defibrillator Using Ultrasound As An Imaging Tool: A Multi-Operator Experience in Radical Use Study
  10. PO-03-064 PREDICTION OF FIRST AND RECURRENT VENTRICULAR ARRHYTHMIA WITH ARTIFICIAL INTELLIGENCE-ENHANCED ECG
  11. PO-03-094 ADAPTIVEECGNET: STATE-OF-THE-ART PERFORMANCE IN MULTI-CLASS INHERITED ARRHYTHMIA DETECTION
  12. Rural–urban disparities in atrial fibrillation–related diagnostic testing and medical procedures in Canada
  13. A Spinning Nightmare of Twiddler's Syndrome?
  14. Evolving burden and consequences of frailty in patients with acute myocardial infarction: evidence from a nationwide cohort
  15. Elucidating the Relationship Between Pacemaker Heart Rates and Pulse Pressure: A Clue to Optimal Programming in Elderly Patients with Cardiovascular Risk
  16. Irreversible left-ventricular lead electrical failure from conductor externalization managed with left bundle branch area pacing: a case report
  17. Safety, Utility, and Outcomes of Procainamide Challenge for the Diagnosis and Exclusion of Brugada Syndrome
  18. Catecholaminergic polymorphic ventricular tachycardia mediated by ryanodine receptor 2: a validated risk stratification
  19. Challenges and strategies in developing high-performance n-type polycrystalline SnSe thermoelectric materials
  20. Prediction of Pulmonary Vein Isolation and Gap Recurrence on 12-Lead ECG Using Deep Learning
  21. Abstract 4357141: Polygenic score analyses in a large multinational HCM clinical cohort identifies effects on disease penetrance and severity
  22. Abstract 4360749: Prevalence and Risk Markers for Heart Failure in Hypertrophic Cardiomyopathy: A Multicenter Cross-Sectional Study With Central Assessment of Biomarkers and Echocardiograms
  23. Behavioural modifications affect the brain phenotype in Takotsubo syndrome
  24. Physical exercise or cognitive behavioural therapy for takotsubo cardiomyopathy: a randomised controlled trial
  25. Rising incidence of STEMI in younger adults: time to redefine premature CAD or a new high-risk group emerging?
  26. Navigating the brain: How cerebral blood flow shifts with task complexity
  27. P116 FLUOROLESS IMPLANTATION OF PACEMAKER AND CARDIOVERTER-DEFIBRILLATOR USING ULTRASOUND AS THE PRIMARY IMAGING TOOL: A MULTI-OPERATOR EXPERIENCE IN RADICAL USE STUDY
  28. P118 IMPACT OF PREGNANCY ON HYPERTROPHIC CARDIOMYOPATHY (HCM): DISEASE PENETRANCE AND RISK FACTORS FOR CARDIOVASCULAR EVENTS
  29. P132 SCOPE AND OUTCOME OF EARLY REPOLARIZATION SYNDROME IN UNEXPLAINED CARDIAC ARREST: INSIGHTS FROM THE NATIONAL HIRO REGISTRY
  30. P137 TOWARDS AUTOMATED DIAGNOSIS OF INHERITED ARRHYTHMIAS: A NEURAL NETWORK FOR COMBINED ARVC AND LQTS CLASSIFICATION
  31. Optimizing Ultrasound‐Guided Placement of Cardiac Implantable Electronic Devices: Current Uses and Challenges
  32. Detecting Arrhythmogenic Right Ventricular Cardiomyopathy From the Electrocardiogram Using Deep Learning
  33. Flecainide for the Treatment of Andersen-Tawil Syndrome
  34. OPTIMAL PACING FOR CEREBRAL PERFUSION: ELUCIDATING RELATIONSHIP BETWEEN PACEMAKER HEART RATE AND PULSE PRESSURE
  35. PO-02-133 TOWARDS AUTOMATED DIAGNOSIS OF INHERITED ARRHYTHMIAS: A NEURAL NETWORK FOR COMBINED ARVC AND LQTS CLASSIFICATION
  36. PO-06-177 VASCULAR AND CARDIAC ULTRASOUND AS THE PRIMARY IMAGING TOOL TO SAFELY DELIVER PACING LEADS WHILE IMPLANTING SINGLE CHAMBER CARDIAC IMPLANTABLE ELECTRONIC DEVICES: RADICAL USE
  37. European Society of Cardiology (ESC) clinical consensus statement on indications for conduction system pacing, with special contribution of the European Heart Rhythm Association of the ESC and endorsed by the Asia Pacific Heart Rhythm Society, the Cana...
  38. Implantable cardiac defibrillator outcomes in octogenarians
  39. The impact of common and rare genetic variants on bradyarrhythmia development
  40. Abstract 4136812: Optimal Pacing for Cerebral Perfusion: Elucidating Relationship Between Resting Pacemaker Heart Rate and Pulse Pressure
  41. The Diagnostic Utility of Holter Monitoring in Catecholaminergic Polymorphic Ventricular Tachycardia
  42. Peak VO2 is associated with cardiac functional response and long-term survival in patients with heart failure and atrial fibrillation undergoing catheter ablation
  43. COMPARATIVE ANALYSIS OF ATRIAL ANATOMICAL VARIATIONS VIA COMPUTED TOMOGRAPHY ANGIOGRAPHY IN PATIENTS WITH AND WITHOUT ATRIAL FIBRILLATION
  44. EXAGGERATED HEART RATE RESPONSE LIMITS PEAK EXERCISE CAPACITY FOR PATIENTS WITH ATRIAL FIBRILLATION
  45. Long-term clinical outcomes and cost-effectiveness of catheter vs thoracoscopic surgical ablation in long-standing persistent atrial fibrillation using continuous cardiac monitoring: CASA-AF randomized controlled trial
  46. High-Risk Nonclassical Long-QT Syndrome Genotypes: Spectrum of Genetic and Phenotypic Features
  47. Mode and Characteristics of Arrhythmia Initiation in Idiopathic Ventricular Fibrillation
  48. A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome
  49. LB-469804-02 LONG-TERM OUTCOMES IN LONG STANDING PERSISTENT ATRIAL FIBRILLATION FOLLOWING CATHETER OR THORACOSCOPIC SURGICAL ABLATION USING CONTINUOUS MONITORING: 3-YEAR FOLLOW-UP OF THE CASA-AF RANDOMISED CONTROLLED TRIAL
  50. Letter to the editor: Re Intraoperative ultrasound–guided pectoral nerve blocks for cardiac implantable device procedures
  51. Meta-Analysis of Genome-Wide Association Studies Reveals Genetic Mechanisms of Supraventricular Arrhythmias
  52. Atrial anatomical variations on computed tomography angiography associated with atrial fibrillation and those predicting recurrence following pulmonary vein isolation
  53. PO-02-169 IMPLANTABLE CARDIAC DEFIBRILLATOR OUTCOMES IN OCTOGENARIANS
  54. PO-05-164 DETECTING ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY USING NEURAL NETWORKS
  55. Implantable Cardioverter-Defibrillators in Octogenarians: An Appeal for a Randomized Clinical Trial
  56. Powering the future: Exploring self‐charging cardiac implantable electronic devices and the Qi revolution
  57. Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure
  58. The Prevalence and Characteristics of Arrhythmic Mitral Valve Prolapse in Patients With Unexplained Cardiac Arrest
  59. Efficacy and safety of supraclavicular and pectoralis nerve blocks as primary peri‐procedural analgesia for cardiac electronic device implantation: A pilot study
  60. Abstract 12595: Vascular and Cardiac Ultrasound as the Primary Imaging Tool to Safely Deliver Pacing Leads While Implanting Single Chamber Cardiac Implantable Electronic Devices. RADICAI USE Investigators
  61. Common and Rare Variant Contributions to Bradyarrhythmias from Multi-Ancestry Meta-Analyses
  62. Conduction system pacing on track to replace CRT? Review of current evidence and prospects of conduction system pacing
  63. Vascular and cardiac ultrasound as the primary imaging tool to safely deliver pacing leads while implanting single-chamber permanent pacemakers: A single-operator experience in a tertiary cardiac center
  64. Ultrasound utilization for implantation of cardiac implantable electronic devices
  65. Left Atrial Function Predicts Atrial Arrhythmia Recurrence Following Ablation of Long-Standing Persistent Atrial Fibrillation
  66. Variation in optimal hemodynamic atrio‐ventricular delay of biventricular pacing with different endocardial left ventricular lead locations using precision hemodynamics
  67. Advancing Commotio cordis Safety Standards Using the Total Human Models for Safety (THUMS)
  68. Management of Inherited Arrhythmia Syndromes: A HiRO Consensus Handbook on Process of Care
  69. Magnetic Resonance Left Ventricle Mass-Index/Fibrosis: Long-Term Predictors for Ventricular Arrhythmia in Hypertrophic Cardiomyopathy—A Retrospective Registry
  70. Incremental value of the signal-averaged ECG for diagnosing arrhythmogenic cardiomyopathy
  71. A First-in-Human Complete Insertion of Single-Chamber Cardiac Pacemaker Using Ultrasound
  72. A Novel Nerve Block Technique for a Patient Undergoing Cardiac Device Implantation
  73. Abstract 11448: Feasibility and Septal Perforation Rates in Left Bundle Branch Area Pacing
  74. Long‐term outcomes following catheter ablation versus medical therapy in patients with persistent atrial fibrillation and heart failure with reduced ejection fraction
  75. The impact of complete versus partial preservation of the sub‐valvular apparatus on left ventricular function in mitral valve replacement
  76. Is it safe to perform total arterial grafting in elderly patients lacking vein grafts? A single surgeon comparison
  77. DIAGNOSTIC UTILITY OF HOLTER MONITORING IN CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
  78. EFFICACY AND SAFTEY OF SUPRACLAVICULAR AND PECTORALIS NERVE BLOCKS AS PRIMARY PERI-PROCEDURAL ANALGESIA FOR CARDIAC ELECTRONIC DEVICE IMPLANTATION: A PILOT STUDY
  79. Sex Differences and Utility of Treadmill Testing in Long‐QT Syndrome
  80. Hemodynamically Tolerated Ventricular Tachycardia With Mildly Impaired Ejection Fraction: Do These Patients Have VT/VF Recurrence and ICD Therapies?
  81. Variation in Optimal Haemodynamic Atrio-ventricular Delay of Biventricular Pacing with Different Endocardial Left Ventricular Lead Locations using Precision Haemodynamics
  82. Novel biomarkers predict ablation outcomes in long stranding persistent atrial fibrillation
  83. PO-686-04 GANGLIONIC PLEXI ABLATION AS PART OF STRATEGY FOR LONG-STANDING PERSISTENT ATRIAL FIBRILLATION RESULTS IN BLUNTED HEART RATE VARIABILITY
  84. Importance of genetic testing in unexplained cardiac arrest
  85. Surgical management and long‐term follow‐up of aberrant right coronary arteries in adults
  86. Biomarkers as predictors of recurrence of atrial fibrillation post ablation: an updated and expanded systematic review and meta-analysis
  87. JAS-GAN: Generative Adversarial Network Based Joint Atrium and Scar Segmentations on Unbalanced Atrial Targets
  88. Utilizing preprocedural imaging and active fixation lead in cardiac resynchronization therapy device upgrade for persistent left superior vena cava
  89. Identifying Vulnerable Impact Locations to Reduce the Occurrence of Deadly Commotio Cordis Events in Children's Baseball: A Computational Approach
  90. Safety of Lead Repair Compared to Lead Revision for Visible Lead Insulation Defects in Patients With Cardiac Implantable Electronic Devices
  91. Hydrogel Paper-Based Analytical Devices: Separation-Free In Situ Assay of Small-Molecule Targets in Whole Blood
  92. Ictal syncope or isolated syncope? A case report highlighting the overlap
  93. LONG-TERM ARRHYTHMIC OUTCOMES AMONG CARDIAC ARREST SURVIVORS WITH PRESERVED EJECTION FRACTION REGISTRY (CASPER)
  94. Thoracoscopic surgical ablation versus catheter ablation as first-line treatment for long-standing persistent atrial fibrillation: the CASA-AF RCT
  95. B-PO02-190 VARIATION IN OPTIMAL HAEMODYNAMIC ATRIO-VENTRICULAR DELAY OF BIVENTRICULAR PACING WITH DIFFERENT ENDOCARDIAL LEFT VENTRICULAR LEAD LOCATIONS USING PRECISION HAEMODYNAMICS
  96. Developing commotio cordis injury metrics for baseball safety: unravelling the connection between chest force and rib deformation to left ventricle strain and pressure
  97. Long-Term Follow-Up of Mortality and Heart Failure Hospitalisation in Patients With Intracardiac Device-Related Tricuspid Regurgitation
  98. Intravenous Methylprednisolone for Ventricular Tachycardia Electrical Storm in Cardiac Sarcoidosis
  99. A case report of inappropriate inhibition of ventricular pacing due to a unique pacemaker electrogram storage feature
  100. Developing Commotio Cordis Injury Metrics by Correlating Chest Force and Rib Deformation to Left Ventricle Strain and Pressure
  101. Utility of 3-D printing for cardiac resynchronization device implantation in congenital heart disease
  102. APPROACH TO THE LEFT SIDED PURKINJE SYSTEM AND LEFT VENTRICLE ENDOCARDIUM DIRECTLY FROM THE RIGHT ATRIUM - POTENTIAL NEW APPROACH TO LBBAP
  103. A simple maneuver to determine if septal accessory pathway ablation requires a left atrial approach
  104. Management of pneumothorax in mechanically ventilated COVID-19 patients: early experience
  105. Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial
  106. What is the mechanism of narrow paced QRS duration during left bundle branch area pacing? A case report
  107. Double chamber cross‐talk, the ultimate double‐cross
  108. Cardiac surgery in patients with confirmed COVID‐19 infection: Early experience
  109. Retrospective analysis of tricuspid valve repair using a novel surgical technique: A 7-year single-surgeon experience
  110. A rare presentation of leakage from vascular space to pericardium and pleura.
  111. P2831Safety of atrial fibrillation catheter ablation in the elderly
  112. New approach to LV lead delivery
  113. 346Left atrial reverse remodelling is not associated with improved success in treatment of long standing persistent atrial fibrillation
  114. Pulsatile sterile abscess in the left breast following transapical transcatheter aortic valve implantation: a case report
  115. How to Induce Arrhythmias with Aminophylline?
  116. Bioprosthetic structural valve deterioration: How do TAVR and SAVR prostheses compare?
  117. P4504A comparison of structural valve deterioration between transcatheter heart valves surgical aortic valve bioprostheses
  118. Role of immunomodulation on heart functiom following heart attack
  119. A comparative study of three-dimensional printing directions: The degradation and toxicological profile of a PLA/PHA blend
  120. rare mediastinal primary tumour with extension into pericardium
  121. Fully automatic segmentation and objective assessment of atrial scars for long‐standing persistent atrial fibrillation patients using late gadolinium‐enhanced MRI
  122. Protocol for CASA AF Trial
  123. Biodegradable PBAT/PLA Blend with Bioactive MCPA-PHBV Conjugate Suppresses Weed Growth
  124. Study comparing keyhole surgical ablation to catheter ablation in treating atrial fibrillation.
  125. 72Heart rate variability evaluation in patients with long standing persistent atrial fibrillation treated with thoracoscopic surgical ablation with ganglionic plexi ablation or catheter ablation - recordings from implantable loop recorder
  126. 71Percutaneous suture closure of the left atrial appendage in patients with a high CHA2DS2 VASC score and absolute contraindication for oral anticoagu-lant therapy – the UNITED KINGDOM experience
  127. P5244Left atrial appendage exclusion as treatment strategy of ablation in longstanding persistent atrial fibrillation does not adversely affect the left atrial function in human
  128. P1464Acute and medium-term outcomes following ablation of complex scar-related atrial tachycardia using a high-resolution mapping system
  129. 131 Left ventricular indexed mass associated with ventricular arrhythmias in patients with hypertrophic cardiomyopathy – a tertiary centre mri registry
  130. 38 A retrospective observational study of fluoroscopy screening services of cardiac devices in a tertiary centre. is the radiation worth it?
  131. A fully automatic deep learning method for atrial scarring segmentation from late gadolinium-enhanced MRI images
  132. Differentiation of pre-ablation and post-ablation late gadolinium-enhanced cardiac MRI scans of longstanding persistent atrial fibrillation patients
  133. Multi-atlas propagation based left atrium segmentation coupled with super-voxel based pulmonary veins delineation in late gadolinium-enhanced cardiac MRI
  134. Evaluation of a novel high-resolution mapping system for catheter ablation of ventricular arrhythmias
  135. Characterising the difference in electrophysiological substrate and outcomes between heart failure and non-heart failure patients with persistent atrial fibrillation
  136. Identification and multi-environment validation of resistance to rust (Uromyces viciae-fabae) in Vicia faba
  137. Segmenting Atrial Fibrosis from Late Gadolinium-Enhanced Cardiac MRI by Deep-Learned Features with Stacked Sparse Auto-Encoders
  138. Response by Panikker et al to Letter Regarding Article, “Left Atrial Appendage Electrical Isolation and Concomitant Device Occlusion to Treat Persistent Atrial Fibrillation: A First-in-Human Safety, Feasibility, and Efficacy Study”
  139. Percutaneous Device Closure of Paravalvular Leak: Combined Experience from the United Kingdom and Ireland
  140. Left Atrial Appendage Electrical Isolation and Concomitant Device Occlusion to Treat Persistent Atrial Fibrillation
  141. Giant Right Coronary Artery Aneurysm
  142. 229-06: Left Atrial Appendage Electrical Isolation for Long-Standing Persistent Atrial Fibrillation: Computational Three-Dimensional Left Atrial Appendage Wall Thickness Maps and Histological Analysis to Guide Ablation
  143. 17-05: Health Economic Analysis of Left Atrial Appendage Closure from Randomised Controlled Trial and Real-World Experience Relative to Oral Anticoagulation by CHA2DS2-VASc sub-group
  144. 140 Two Decades of Mitral Valve Surgery – Trends and Outcomes in Elderly Patients
  145. Papillary Fibroelastoma Causing Left Ventricular Outflow Obstruction and Systolic Anterior Motion (SAM)
  146. Outcome and costs of LAA closure in a randomised control trial and real world experience
  147. Modified Thoracoplasty Using a Breast Implant to Obliterate an Infected Pleural Space: An Alternative to Traditional Thoracoplasty
  148. Prognostic importance of tissue velocity imaging during exercise echocardiography in patients with systolic heart failure
  149. Benign intracranial hypertension - Pseudotumour Cerebri
  150. Review of clinical cardiac MRI
  151. Tissue Doppler–Derived Contractile Reserve Is a Simple and Strong Predictor of Cardiopulmonary Exercise Performance across a Range of Cardiac Diseases
  152. A Comparison of High Intensity Interval Training with Circuit Training in a Short-Term Cardiac Rehabilitation Programme for Patients with Chronic Heart Failure
  153. Unusual presentation of a chondrosarcoma as an anterior mediastinal mass
  154. Accessory Mitral Valve Associated with Transient Ischemic Attacks
  155. A rare case of an aberrant anterior mitral valve chord resulting in severe mitral regurgitation
  156. Early Failure of Coronary Artery Bypass Grafts: An Albumin Cross-Linked Glutaraldehyde (BioGlue) Related Complication
  157. Cardiac ischaemia and rhythm disturbances during elective colonoscopy
  158. S1409: Colonoscopy and Bowel Preparation - Are There More Risks Than Observed?
  159. S1408: An Effective Scoring System to Assess the Cardiac Risks of Colonoscopy
  160. Faba bean breeding for drought-affected environments: A physiological and agronomic perspective
  161. Colonoscopy - Health Gains But Heart Strains?
  162. 59th Annual General Meeting of the Irish Cardiac Society
  163. Screening techniques and sources of resistance to abiotic stresses in cool-season food legumes
  164. Zinc fertilization and water stress affects plant water relations, stomatal conductance and osmotic adjustment in chickpea (Cicer arientinum L.)
  165. Zn fertilization improves water use efficiency, grain yield and seed Zn content in chickpea
  166. Response of chickpea genotypes to zinc fertilization under field conditions in south Australia and Pakistan
  167. Assessment of the Zn status of chickpea by plant analysis
  168. Chickpea genotypes differ in their sensitivity to Zn deficiency
  169. Left Atrial Scarring Segmentation from Delayed-Enhancement Cardiac MRI Images: A Deep Learning Approach